Which condition should be treated first: ADHD or mood disorder?

PostedNovember 20, 2025

UpdatedNovember 21, 2025

ByMy Patient Advice

Author: Harriet Winslow, BSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

When ADHD occurs alongside a mood disorder such as anxiety, depression, or bipolar disorder, deciding which condition to treat first can be complex. According to NICE guidance on ADHD (NG87) and the Royal College of Psychiatrists (CR235), treatment sequencing should be guided by symptom severity, functional impact, and overall stability. In general, most clinicians stabilise severe mood symptoms first, while mild or stable mood issues can be managed alongside ADHD treatment under specialist supervision.

NICE and NHS guidance on treatment sequencing

NICE advises that treatment plans must address both ADHD and psychiatric comorbidities, prioritising the condition that causes the greatest impairment. When a significant mood disorder is present, NICE guidance for depression, anxiety, and bipolar disorder (CG185) and the NHS ADHD overview recommend stabilising mood first. This often involves antidepressants, psychological therapy, or mood stabilisers, before reassessing ADHD symptoms.

In cases of bipolar disorder, NICE warns that stimulant medications can trigger manic episodes, so mood stabilisation with lithium or valproate should come before ADHD pharmacotherapy. For individuals with both ADHD and anxiety or depression, non-stimulant medication such as atomoxetine may be considered because it can benefit both conditions with a lower risk of mood destabilisation.

NHS and RCPsych clinical recommendations

The NHS Shared Care Protocols (2025) and RCPsych ADHD guidance (CR235) both advise that medication sequencing should depend on which disorder is most impairing or unstable. Stimulant or non-stimulant ADHD medication should only begin when mood symptoms are controlled or mild. Multidisciplinary teams are encouraged to review emotional stability, developmental history, and collateral information before starting treatment.

Research and treatment outcomes

A 2025 PubMed meta-analysis found that treating severe mood symptoms first led to better outcomes and safety. However, early ADHD treatment was beneficial when mood disorders were mild or stable. Another PubMed study (2025) showed that using mood stabilisers alongside ADHD medication, particularly methylphenidate or atomoxetine, improved emotional regulation and overall functioning.

Key takeaway

NICE, NHS, and RCPsych guidance agree that the most unstable or impairing condition should be treated first. When mood disorders are severe, mood stabilisation should come before ADHD medication. In mild or stable cases, both can be managed concurrently with careful monitoring. Regular multidisciplinary reviews and cautious medication selection, especially for bipolar disorder, remain essential to ensure effective and safe treatment.

Harriet Winslow, BSc

Author

Harriet Winslow is a clinical psychologist with a Bachelor’s in Clinical Psychology and extensive experience in behaviour therapy and developmental disorders. She has worked with children and adolescents with ADHD, autism spectrum disorder (ASD), learning disabilities, and behavioural challenges, providing individual and group therapy using evidence-based approaches such as CBT and DBT. Dr. Winslow has developed and implemented personalised treatment plans, conducted formal and informal assessments, and delivered crisis intervention for clients in need of urgent mental health care. Her expertise spans assessment, treatment planning, and behavioural intervention for both neurodevelopmental and mental health conditions.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.